Disclosed is a combination comprising a 21-substituted 19-norpregnadiene of formula (I) and an aromatase inhibitor. Specific examples of aromatase inhibitors are anastrozole, letrozole, exemestane and DL-aminoglutethimide. Specific examples of compound of formula (I) include: 21-propionyloxy-17[alpha]-acetoxy-11[beta]-(4N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, and 21-vinyl ether-17[alpha]-acetoxy-11[beta]-(4N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione The combination is useful for suppressing breast cancer tissue proliferation